Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of Subcutaneous Proleukin (interleukin-2) in a Randomized International Trial (ESPRIT): geographical and gender differences in the baseline characteristics of participants.
Pett SL, Wand H, Law MG, Arduino R, Lopez JC, Knysz B, Pereira LC, Pollack S, Reiss P, Tambussi G; ESPRIT Research Group. Pett SL, et al. Among authors: wand h. HIV Clin Trials. 2006 Mar-Apr;7(2):70-85. doi: 10.1310/4733-acqf-f3p4-2qac. HIV Clin Trials. 2006. PMID: 16798622 Free article.
A randomised trial of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients: the UK-Vanguard Study.
Youle M, Emery S, Fisher M, Nelson M, Fosdick L, Janossy G, Loveday C, Sullivan A, Herzmann C, Wand H, Davey RT Jr, Johnson MA, Tavel JA, Lane HC. Youle M, et al. Among authors: wand h. PLoS Clin Trials. 2006 May;1(1):e3. doi: 10.1371/journal.pctr.0010003. Epub 2006 May 19. PLoS Clin Trials. 2006. PMID: 16871325 Free PMC article.
Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A. Samaras K, et al. Among authors: wand h. Diabetes Care. 2007 Jan;30(1):113-9. doi: 10.2337/dc06-1075. Diabetes Care. 2007. PMID: 17192343
Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy.
Calmy A, Carey D, Mallon PW, Wand H, Law M, Cooper DA, Carr A; INITIO Trial International Co-ordinating Committee; HAMA study coordination team. Calmy A, et al. Among authors: wand h. HIV Med. 2008 Feb;9(2):101-10. doi: 10.1111/j.1468-1293.2007.00527.x. HIV Med. 2008. PMID: 18257772 Free article. Clinical Trial.
363 results